EKG vs. IDNA
Compare and contrast key facts about First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA).
EKG and IDNA are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. EKG is a passively managed fund by First Trust that tracks the performance of the NASDAQ Lux Health Tech Index. It was launched on Mar 22, 2022. IDNA is a passively managed fund by iShares that tracks the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index. It was launched on Jun 11, 2019. Both EKG and IDNA are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
EKG vs. IDNA - Performance Comparison
Loading graphics...
EKG vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | -14.04% | 11.89% | 6.53% | -0.11% | -19.59% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 11.45% | 17.26% | -0.72% | -7.63% | -26.25% |
Returns By Period
In the year-to-date period, EKG achieves a -14.04% return, which is significantly lower than IDNA's 11.45% return.
EKG
- 1D
- 0.64%
- 1M
- -8.58%
- YTD
- -14.04%
- 6M
- -6.60%
- 1Y
- 4.53%
- 3Y*
- -1.55%
- 5Y*
- —
- 10Y*
- —
IDNA
- 1D
- 0.48%
- 1M
- -5.56%
- YTD
- 11.45%
- 6M
- 20.68%
- 1Y
- 48.06%
- 3Y*
- 9.03%
- 5Y*
- -7.93%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
EKG vs. IDNA - Expense Ratio Comparison
EKG has a 0.65% expense ratio, which is higher than IDNA's 0.47% expense ratio.
Return for Risk
EKG vs. IDNA — Risk / Return Rank
EKG
IDNA
EKG vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EKG | IDNA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.18 | 1.75 | -1.56 |
Sortino ratioReturn per unit of downside risk | 0.45 | 2.40 | -1.95 |
Omega ratioGain probability vs. loss probability | 1.06 | 1.29 | -0.23 |
Calmar ratioReturn relative to maximum drawdown | 0.20 | 3.66 | -3.46 |
Martin ratioReturn relative to average drawdown | 0.67 | 11.65 | -10.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| EKG | IDNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.18 | 1.75 | -1.56 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.28 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.18 | 0.11 | -0.28 |
Correlation
The correlation between EKG and IDNA is 0.67, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
EKG vs. IDNA - Dividend Comparison
EKG has not paid dividends to shareholders, while IDNA's dividend yield for the trailing twelve months is around 1.06%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.06% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Drawdowns
EKG vs. IDNA - Drawdown Comparison
The maximum EKG drawdown since its inception was -43.82%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for EKG and IDNA.
Loading graphics...
Drawdown Indicators
| EKG | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.82% | -68.26% | +24.44% |
Max Drawdown (1Y)Largest decline over 1 year | -21.99% | -12.11% | -9.88% |
Max Drawdown (5Y)Largest decline over 5 years | — | -68.26% | — |
Current DrawdownCurrent decline from peak | -24.25% | -45.05% | +20.80% |
Average DrawdownAverage peak-to-trough decline | -22.65% | -36.05% | +13.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.54% | 3.81% | +2.73% |
Volatility
EKG vs. IDNA - Volatility Comparison
The current volatility for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) is 8.01%, while iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a volatility of 9.54%. This indicates that EKG experiences smaller price fluctuations and is considered to be less risky than IDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| EKG | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.01% | 9.54% | -1.53% |
Volatility (6M)Calculated over the trailing 6-month period | 14.42% | 18.22% | -3.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.71% | 27.75% | -3.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.07% | 28.53% | -1.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.07% | 29.68% | -2.61% |